Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Abraham Attah Attah"'
Autor:
Abhishek Chaturvedi, Veli Bakalov, Michael Turk, Patrick Wedgeworth, Thejus T. Jayakrishnan, Nada Alrifai, Adeel Nasrullah, Aaron Haag, Melissa Mosley, Laith Alhuneafat, Abraham Attah Attah, Swathi Sangli, Fadi Khoury, Shane Mealy, Kirtivardan Vashistha, Corbyn Minich
Publikováno v:
Journal of Clinical Medicine; Volume 10; Issue 23; Pages: 5652
Journal of Clinical Medicine
Journal of Clinical Medicine, Vol 10, Iss 5652, p 5652 (2021)
Journal of Clinical Medicine
Journal of Clinical Medicine, Vol 10, Iss 5652, p 5652 (2021)
Introduction: Thrombosis and bleeding are recognized complications of the novel coronavirus infection (COVID-19), with a higher incidence described particularly in the critically ill. Methods: A retrospective review of COVID-19 patients admitted to o
Autor:
Palash Asawa, Urwat Til Vusqa, Rahul Karna, Abraham Attah Attah, Ryan Sweeney, Shivani Shah, Thejus Jayakrishnan, Srividya Srinivasamaharaj, Yazan Samhouri, Dulabh K. Monga
Publikováno v:
Journal of Clinical Oncology. 40:e16246-e16246
e16246 Background: Obesity has been identified as a risk factor for pancreatic cancer. The prevalence of obesity has been on a rise in the last two decades. Obesity is defined by the world health organization (WHO) as body mass index (BMI) > 30.0 kg/
Autor:
Robin Raquel Rodriguez, Stephen Abel, Veli Bakalov, Herman Lo, Abraham Attah Attah, Khaled Alhamad, Karthik Shankar, Muhammad Yasir, Ashish Sethi, Gene Grant Finley, Saleha Rizwan, Andrew Friday, Talal Khan
Publikováno v:
Journal of Clinical Oncology. 39:e21213-e21213
e21213 Background: Lung cancer is the leading cause of death in males and females in the United States. Approximately 85% of all cases are classified as non-small cell lung cancer (NSCLC) with majority diagnosed at an advanced stage. Unfortunately, r
Autor:
Palash Asawa, Khaled Alhamad, Chelsea Peterson, Adriani Cherico, Dulabh Monga, Karthik Shankar, Abraham Attah Attah, Yazan Samhouri, Pragnan Kancharla, Thejus T. Jayakrishnan, Nada Alrifai, Nkechi Onokwai, Saleha Rizwan, Srividya Srinivasamaharaj, Deanna Huffman
Publikováno v:
Journal of Clinical Oncology. 39:e16258-e16258
e16258 Background: Cytotoxic chemotherapy remains the standard of care in the treatment of pancreatic ductal adenocarcinoma (PDAC). There is more excitement in the last few years regarding the use of neoadjuvant chemotherapy even when the disease is
Autor:
Abraham Attah Attah, Palash Asawa, Yazan Samhouri, Srividya Srinivasamaharaj, Khaled Alhamad, Karthik Shankar, Lynna Alnimer, Dulabh Monga, Micheal Turk, Saleha Rizwan
Publikováno v:
Journal of Clinical Oncology. 39:e16247-e16247
e16247 Background: Pancreatic ductal adenocarcinoma (PDAC) remains one of the most lethal solid tumors, predicted to become the second leading cause of cancer related death in some regions of the world. It often presents at an advanced stage, which c
Autor:
Karthik Shankar, Lynna Alnimer, Srividya Srinivasamaharaj, Abraham Attah Attah, Yazan Samhouri, Thejus T. Jayakrishnan, Nada Alrifai, Khaled Alhamad, Dulabh Monga
Publikováno v:
Journal of Clinical Oncology. 39:e18610-e18610
e18610 Background: Early stage pancreatic ductal adenocarcinoma (PDAC) account for up to 30% of newly diagnosed patients. Until recently, the mainstay of treatment remained curative-intent surgery followed by adjuvant chemotherapy. More recently, the